fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

The EBA pharma community continues to support Ukraine in wartime

14/ 04/ 2022
  The EBA Health Care Committee member companies continue to support Ukraine’s healthcare system by providing humanitarian assistance to patients and the country, including vital medicines, medical supplies, as well as financial assistance to charities and international foundations. Since the outbreak of russia’s aggression against Ukraine, the EBA pharmaceutical community, including AbbVie, Adamed, Arterium, AstraZeneca, Bayer, Berlin-Chemie, Boehringer Ingelheim International GmbH, Darnitsa, Egis, Farmak, GSK, MSD, Novartis, Orion Pharma, Pfizer, Philips, Roche Diagnostics, Sandoz, Sanofi, Takeda, Teva, UСB, Wörwag Pharma provided assistance to Ukraine for nearly $ 117.8 million which is more than UAH 3.5 billion. Thus, AbbVie provided $ 1 million in charitable assistance to the International Medical Corps and the Hope Project for medical care and supplies for Ukraine and Ukrainian refugees. AbbVie also provides essential medicines to the Government of Ukraine and disaster relief partners. The company has doubled the sum of staff donations from AbbVie Foundation to selected disaster relief partners that are actively involved in providing humanitarian assistance in Ukraine and neighbouring countries. Adamed provided more than PLN 4.3 million in medicines and medical supplies and is constantly coordinating with the Polish government, government agencies (including the Government Agency for Strategic Reserves), local governments, and disaster relief organizations. In the long run, Adamed plans to provide financial assistance to priority initiatives and support partner charities to consolidate efforts. Arterium provided medicines of its own production for UAH 17.7 million as humanitarian aid. AstraZeneca contributed to Ukraine more than $ 7 million by: Providing humanitarian assistance to Ukrainian patients with its medicines worth $ 3 million transferred from AstraZeneca’s warehouse in Ukraine directly to the Ministry of Health of Ukraine with the involvement of Direct Relief (an international partner in the supply of humanitarian aid). Assistance includes innovative oncological drugs, drugs for the treatment of type 2 diabetes, cardiovascular and respiratory diseases, and others. Providing $ 2 million to support relief organizations, focusing on health care and humanitarian assistance to those affected. The main fund recipients are the Hope Project and International Medical Corps. Providing medicines to Red Cross affiliates in neighbouring countries as a response to the refugee crisis. AstraZeneca employees around the world have also made charitable contributions that amounted to more than $500 thousand (as of March 21, 2022). They were designated to UNICEF and the Red Cross. Moreover, AstraZeneca doubled the sum, so the total contribution reached over $1 million. Bayer set up a support fund of € 3 million for international and local humanitarian organizations operating in Ukraine and Eastern Europe. The fund includes initial assistance of €300,000 to the Red Cross and local organizations, provided immediately on the first day of the invasion. Bayer employees have made charitable contributions of more than €900,000 through the German Red Cross. The company will double all employee contributions to increase support. At the request of the Ministry of Health of Ukraine, Bayer provided the first batch of antibiotics and sterile materials that would help provide up to 27,000 patients. In addition to the initial donation, Berlin-Chemie made another donation of € 200,000 directly to the Red Cross, while its staff worldwide raised almost € 60,000, totaling around € 420,000 of donations to the Red Cross. Taking into account the donation of medicines, the Berlin-Chemies total charitable contribution today exceeds 1 million euros. The company also stopped all advertising costs in Russia, all new investments, and it stopped hiring new employees. Boehringer Ingelheim donated € 2.5 million to charitable organizations that provide humanitarian assistance to Ukraine and its citizens. The company is also considering the possibility of air transportation of cardiovascular, metabolic, and respiratory drugs from the United States to Poland after which the products will be delivered by truck to the Ministry of Health of Ukraine and/or non-governmental partner organizations. Darnitsa donated almost 600,000 packages of medicines free of charge to medical institutions and volunteer organizations that help the Ukrainian military and civilians. Darnitsa medicines worth a total of 26.6 million hryvnias were donated to the Main Military Hospital, Kyiv City Clinical Ambulance Hospital, Kyiv City Clinical Hospital №17, National Heart Institute, Okhmatdyt, Zakarpattia Territorial Center for Emergency Medical Care, charity foundations “Come Back Alive” and Tabletochki, Zhytomyr City Council, Kozelets Intensive Care Hospital, military units. The company imported at its own expense a strategic hemostatic (extremely important for the army), 10 thousand packages of which were donated to hospitals, territorial defense units, and Armed Forces. The company resumed production of even more strategically important categories of drugs: infusion solutions, ointments, tablets. Medicines are delivered to almost all hot spots such as Mariupol, Kharkiv, Kyiv, and Zhytomyr. Darnitsa sent its pharmaceutical-educated staff to help pharmacy networks as volunteer pharmacists free of charge. So far, more than 40 employees of the company with a pharmaceutical education have applied for a job in pharmacies on a volunteer basis. Egis in Hungary provided humanitarian aid of USD 500 thousand to Ukrainian patients and provided the Ministry of Health of Ukraine with antiseptics, antidepressants, antimicrobials, cardiac drugs, and other drugs for emergency care. The company offered further humanitarian aid of HUF 100 million and planned additional supplies of medicines to the Ministry of Health of Ukraine for the benefit of patients. Farmak and the Zhebrovsky Family Charitable Foundation have been supporting the Armed Forces of Ukraine since the first days of the war in 2014. Prior to the full-scale military invasion of the russian occupiers into the territory of Ukraine and after it, the company has been transferring medical equipment, protective structures, bulletproof vests, first aid kits, and medicines. The total amount of charitable assistance to medical institutions, the Armed Forces, territorial defense, and the people amounted to approximately UAH 5.8 million from December 2021 to date. Of these, about UAH 4.2 million are medicines. Besides, from the first days of the invasion, Farmak has been providing logistics assistance to the Public Health Center of the Ministry of Health of Ukraine, which includes nine trucks with drugs, some of which have already been unloaded in Ukraine. GlaxoSmithKline donated GBP 3.25 million to the Red Cross and Save the Children and GBP 250 thousand to Crown Agents for the purchase of 2.5 thousand first aid kits required by the MoH. Through ViiV Healthcare GSK, WHO antiretroviral drugs were donated to national AIDS programs and nonprofits to support children and adults with HIV affected by the conflict. ViiV also received an initial GBP 200,000 through GlaxoSmithKlines Positive Action program. GlaxoSmithKline targets more than 500,000 units of medicines and consumer products, including antibiotics, asthma medications, epilepsy medications, and painkillers. GlaxoSmithKline employees around the world have made donations of more than GBP 300,000 to help Save the Children and the Red Cross. MSD provided more than $ 65 million in charitable assistance. $ 1 million were to the American Red Cross, Direct Relief, the International Medical Corps, and the HOPE project to provide emergency assistance to victims in the regions. MSD delivers expensive medicines to Ukrainian citizens and refugees for the treatment of asthma, infections and cancer. MSD provided animal vaccines from Merck Animal Health to Ukrainian farmers to support continued livestock and food production. Novartis joined the humanitarian effort and provided $ 3 million in charitable assistance to three humanitarian organizations: the International Red Cross and Red Crescent Movement, the Save the Children Charitable Foundation, and the International Rescue Committee. The company is expanding its humanitarian activities by providing free stocks of medicines within Ukraine, including the necessary antibiotics and painkillers, as well as other products for use in medical institutions. Novartis provides about 600,000 packs of drugs: antibiotics, painkillers, cardiovascular and cancer drugs. Novartis in Ukraine is represented by Sandoz Ukraine LLC and Novartis Pharma Services AG. Orion Pharma sent charitable aid in the amount of € 51 thousand to the Finnish Red Cross to help the victims of the war in Ukraine. Pfizer initiated a number of humanitarian events and helped increase support for Ukraine at this difficult time. The Pfizer Foundation, a charitable organization, has provided a $ 1 million humanitarian grant to organizations operating in Ukraine and neighbouring countries, including: The American Red Cross to provide support to ambulance crews, medical facilities to provide medicines and medical equipment, social support to families, and assistance in repairing vital infrastructure; International Medical Corps to support operational services of emergency and primary health care; The International Rescue Committee in support of efforts in border countries for the mobilization of resources. A campaign was launched to enable all staff members to provide charitable assistance to key organizations helping victims of the conflict in Ukraine and neighboring countries. The company also provided humanitarian assistance for the urgent needs of military hospitals and clinics at their request, as well as provided medicines for patients suffering from chronic diseases (R&D, cancer and cardiovascular disease). The total aid amounts to about 2 million US dollars. Philips works hard to help victims of Russian aggression in the following areas: Hospital Assistance - the Philips Foundation provides a 20-bed mobile hospital equipped with Philips monitors, electrocardiographs and portable diagnostic ultrasound devices; Emergency support - installation of 60 mobile diagnostic devices using Philips portable ultrasonic diagnostic technology and 5 mobile diagnostic X-rays; Assistance to those in need - provision of Philips Avent appliances and products (breast pumps, sterilizers, bottles, pacifiers, and milk storage bags) to those organizations that currently need them, including the territorial defense units, hospitals, clinics, volunteer organizations; Financial support and necessary supplies for Ukrainian migrants - support for Ukrainian migrants on the Romanian and Polish borders to cover living and travel expenses, as well as support for mothers and children in the form of respirators and portable Philips ultrasound devices for use in special medical tents. Program for donations from Philips employees - enabling employees to donate through the Philips Foundation for people in Ukraine. Roche sent humanitarian aid to the Ministry of Health of Ukraine in the form of medicines and medical devices, namely: Reagents and consumables for HIV, HCV, HBV, and syphilis automated testing. This is necessary to make 120,000 blood donations and ensure the necessary supply of safe blood and blood components; 31,000 units for the treatment of diabetes, including blood glucose monitoring systems and puncture devices; 4,600 packs of drugs for the treatment of lung, breast, and skin cancer, rheumatoid arthritis, spinal muscular atrophy and influenza. Besides, Roche is committed to providing 150,000 packs of antibiotics for various types of bacterial infections. 75,000 packages of this antibiotic were delivered to the Ministry of Health of Ukraine. Roche created a special program, Ukrainian Refugee Continuity of Care (UREFCON) to provide ongoing care to displaced Ukrainian patients. Roche set up a global hotline for patients receiving treatment in Ukraine, participating in clinical trials or Compassionate Drug Use Programme (worldwide: tel: +36 146 182 58, WhatsApp and SMS +36 707 177 394 and e-mail: patientcare@roche.com) to sustain the therapy. A separate global support program was developed for patients with spinal muscular atrophy (SMA). The program provides uninterrupted access to treatment for all patients in Ukraine or from Ukraine who are currently receiving Roches SMA treatment. These include patients receiving Roches SMA treatment as part of our clinical trials, pre-registration access/compassionate medications, or other commercial methods (ie, self-funded or government-funded programs in Ukraine). The program supports patients who are currently in Ukraine or those who have left the country due to the war. Since the first days of the war, Sanofi has been cooperating closely with the Ministry of Health of Ukraine and providing vital drugs to the regions of Ukraine. Globally, the company has provided € 5 million in assistance to the Red Cross in Ukraine and neighbouring European countries to the Office of the United Nations High Commissioner for Refugees. Sanofi coordinates and provides essential medicines and vaccines to support Ukrainian patients and refugees. Sanofi has received 10.5 million single doses (insulins, antiepileptics, emergency medications) that will provide treatment to nearly 360 thousand patients. Takeda joined the global humanitarian effort and provided 300 million Japanese yen (approximately $ 2.6 million) to the International Federation of Red Cross and Red Crescent Societies for immediate humanitarian assistance on the ground to IDPs and victims of russian aggression. Takeda also transferred UAH 400,000 to the Ukrainian Red Cross. The company provides free medicines to hospitals. Takeda employees make personal donations to several local and global NGOs. Teva provided charitable assistance with essential medicines in the sum of 11 million US dollars. Teva shipped more than 1.3 million packages of medicines, including antibiotics and other drugs included in the WHO list of essential medicines, as well as products for Ukrainian infants and children suffering from poor sanitation. Teva provided more than 350,000 packages of medicines to the Ministry of Health of Ukraine for 756 thousand US dollars as charitable assistance. In support of the humanitarian effort, UСB provided € 300,000 to the International Rescue Committee and the Belgian Red Cross. UСB delivered 5,000 antiepileptic drugs and 5,000 antiallergic drugs through Tulipe to help Ukrainian patients. Wörwag Pharma provided humanitarian aid in the sum of UAH 650,000 for the purchase of essential medicines and donated medicines directly through a Ukrainian charity for 60,000 euros. The EBA Health Care Committee is very grateful to its member companies for their incredible efforts in ensuring the continued supply of medicines and medical equipment to Ukrainian patients in these difficult times. We are proud of the implementation of this substantial humanitarian support. Devotion to patients is a top priority for the medical and pharmaceutical community, and this priority must be increased especially given the atrocities happening around. So, we continue to do everything to bring victory to Ukraine as soon as possible! Glory to Ukraine! Glory to the Heroes!

The EBA Health Care Committee member companies continue to support Ukraine’s healthcare system by providing humanitarian assistance to patients and the country, including vital medicines, medical supplies, as well as financial assistance to charities and international foundations.

Since the outbreak of russia’s aggression against Ukraine, the EBA pharmaceutical community, including AbbVie, Adamed, Arterium, AstraZeneca, Bayer, Berlin-Chemie, Boehringer Ingelheim International GmbH, Darnitsa, Egis, Farmak, GSK, MSD, Novartis, Orion Pharma, Pfizer, Philips, Roche Diagnostics, Sandoz, Sanofi, Takeda, Teva, UСB, Wörwag Pharma provided assistance to Ukraine for nearly $ 117.8 million which is more than UAH 3.5 billion.

Thus, AbbVie provided $ 1 million in charitable assistance to the International Medical Corps and the Hope Project for medical care and supplies for Ukraine and Ukrainian refugees. AbbVie also provides essential medicines to the Government of Ukraine and disaster relief partners. The company has doubled the sum of staff donations from AbbVie Foundation to selected disaster relief partners that are actively involved in providing humanitarian assistance in Ukraine and neighbouring countries.

Adamed provided more than PLN 4.3 million in medicines and medical supplies and is constantly coordinating with the Polish government, government agencies (including the Government Agency for Strategic Reserves), local governments, and disaster relief organizations. In the long run, Adamed plans to provide financial assistance to priority initiatives and support partner charities to consolidate efforts.

Arterium provided medicines of its own production for UAH 17.7 million as humanitarian aid.

AstraZeneca contributed to Ukraine more than $ 7 million by:

Providing humanitarian assistance to Ukrainian patients with its medicines worth $ 3 million transferred from AstraZeneca’s warehouse in Ukraine directly to the Ministry of Health of Ukraine with the involvement of Direct Relief (an international partner in the supply of humanitarian aid). Assistance includes innovative oncological drugs, drugs for the treatment of type 2 diabetes, cardiovascular and respiratory diseases, and others.

Providing $ 2 million to support relief organizations, focusing on health care and humanitarian assistance to those affected. The main fund recipients are the Hope Project and International Medical Corps.

Providing medicines to Red Cross affiliates in neighbouring countries as a response to the refugee crisis.

AstraZeneca employees around the world have also made charitable contributions that amounted to more than $500 thousand (as of March 21, 2022). They were designated to UNICEF and the Red Cross. Moreover, AstraZeneca doubled the sum, so the total contribution reached over $1 million.

Bayer set up a support fund of € 3 million for international and local humanitarian organizations operating in Ukraine and Eastern Europe. The fund includes initial assistance of €300,000 to the Red Cross and local organizations, provided immediately on the first day of the invasion. Bayer employees have made charitable contributions of more than €900,000 through the German Red Cross. The company will double all employee contributions to increase support. At the request of the Ministry of Health of Ukraine, Bayer provided the first batch of antibiotics and sterile materials that would help provide up to 27,000 patients.

In addition to the initial donation, Berlin-Chemie made another donation of € 200,000 directly to the Red Cross, while its staff worldwide raised almost € 60,000, totaling around € 420,000 of donations to the Red Cross. Taking into account the donation of medicines, the Berlin-Chemie’s total charitable contribution today exceeds 1 million euros. The company also stopped all advertising costs in Russia, all new investments, and it stopped hiring new employees.

Boehringer Ingelheim donated € 2.5 million to charitable organizations that provide humanitarian assistance to Ukraine and its citizens. The company is also considering the possibility of air transportation of cardiovascular, metabolic, and respiratory drugs from the United States to Poland after which the products will be delivered by truck to the Ministry of Health of Ukraine and/or non-governmental partner organizations.

Darnitsa donated almost 600,000 packages of medicines free of charge to medical institutions and volunteer organizations that help the Ukrainian military and civilians. Darnitsa medicines worth a total of 26.6 million hryvnias were donated to the Main Military Hospital, Kyiv City Clinical Ambulance Hospital, Kyiv City Clinical Hospital №17, National Heart Institute, Okhmatdyt, Zakarpattia Territorial Center for Emergency Medical Care, charity foundations “Come Back Alive” and “Tabletochki”, Zhytomyr City Council, Kozelets Intensive Care Hospital, military units. The company imported at its own expense a strategic hemostatic (extremely important for the army), 10 thousand packages of which were donated to hospitals, territorial defense units, and Armed Forces.

The company resumed production of even more strategically important categories of drugs: infusion solutions, ointments, tablets. Medicines are delivered to almost all “hot” spots such as Mariupol, Kharkiv, Kyiv, and Zhytomyr. Darnitsa sent its pharmaceutical-educated staff to help pharmacy networks as volunteer pharmacists free of charge. So far, more than 40 employees of the company with a pharmaceutical education have applied for a job in pharmacies on a volunteer basis.

Egis in Hungary provided humanitarian aid of USD 500 thousand to Ukrainian patients and provided the Ministry of Health of Ukraine with antiseptics, antidepressants, antimicrobials, cardiac drugs, and other drugs for emergency care. The company offered further humanitarian aid of HUF 100 million and planned additional supplies of medicines to the Ministry of Health of Ukraine for the benefit of patients.

Farmak and the Zhebrovsky Family Charitable Foundation have been supporting the Armed Forces of Ukraine since the first days of the war in 2014. Prior to the full-scale military invasion of the russian occupiers into the territory of Ukraine and after it, the company has been transferring medical equipment, protective structures, bulletproof vests, first aid kits, and medicines. The total amount of charitable assistance to medical institutions, the Armed Forces, territorial defense, and the people amounted to approximately UAH 5.8 million from December 2021 to date. Of these, about UAH 4.2 million are medicines. Besides, from the first days of the invasion, Farmak has been providing logistics assistance to the Public Health Center of the Ministry of Health of Ukraine, which includes nine trucks with drugs, some of which have already been unloaded in Ukraine.

GlaxoSmithKline donated GBP 3.25 million to the Red Cross and Save the Children and GBP 250 thousand to Crown Agents for the purchase of 2.5 thousand first aid kits required by the MoH. Through ViiV Healthcare GSK, WHO antiretroviral drugs were donated to national AIDS programs and nonprofits to support children and adults with HIV affected by the conflict. ViiV also received an initial GBP 200,000 through GlaxoSmithKline’s Positive Action program. GlaxoSmithKline targets more than 500,000 units of medicines and consumer products, including antibiotics, asthma medications, epilepsy medications, and painkillers. GlaxoSmithKline employees around the world have made donations of more than GBP 300,000 to help Save the Children and the Red Cross.

MSD provided more than $ 65 million in charitable assistance. $ 1 million were to the American Red Cross, Direct Relief, the International Medical Corps, and the HOPE project to provide emergency assistance to victims in the regions. MSD delivers expensive medicines to Ukrainian citizens and refugees for the treatment of asthma, infections and cancer. MSD provided animal vaccines from Merck Animal Health to Ukrainian farmers to support continued livestock and food production.

Novartis joined the humanitarian effort and provided $ 3 million in charitable assistance to three humanitarian organizations: the International Red Cross and Red Crescent Movement, the Save the Children Charitable Foundation, and the International Rescue Committee. The company is expanding its humanitarian activities by providing free stocks of medicines within Ukraine, including the necessary antibiotics and painkillers, as well as other products for use in medical institutions. Novartis provides about 600,000 packs of drugs: antibiotics, painkillers, cardiovascular and cancer drugs.

Novartis in Ukraine is represented by Sandoz Ukraine LLC and Novartis Pharma Services AG.

Orion Pharma sent charitable aid in the amount of € 51 thousand to the Finnish Red Cross to help the victims of the war in Ukraine.

Pfizer initiated a number of humanitarian events and helped increase support for Ukraine at this difficult time. The Pfizer Foundation, a charitable organization, has provided a $ 1 million humanitarian grant to organizations operating in Ukraine and neighbouring countries, including:

  • The American Red Cross to provide support to ambulance crews, medical facilities to provide medicines and medical equipment, social support to families, and assistance in repairing vital infrastructure;
  • International Medical Corps to support operational services of emergency and primary health care;
  • The International Rescue Committee in support of efforts in border countries for the mobilization of resources.

A campaign was launched to enable all staff members to provide charitable assistance to key organizations helping victims of the conflict in Ukraine and neighboring countries. The company also provided humanitarian assistance for the urgent needs of military hospitals and clinics at their request, as well as provided medicines for patients suffering from chronic diseases (R&D, cancer and cardiovascular disease). The total aid amounts to about 2 million US dollars.

Philips works hard to help victims of Russian aggression in the following areas:

  • Hospital Assistance – the Philips Foundation provides a 20-bed mobile hospital equipped with Philips monitors, electrocardiographs and portable diagnostic ultrasound devices;
  • Emergency support – installation of 60 mobile diagnostic devices using Philips portable ultrasonic diagnostic technology and 5 mobile diagnostic X-rays;
  • Assistance to those in need – provision of Philips Avent appliances and products (breast pumps, sterilizers, bottles, pacifiers, and milk storage bags) to those organizations that currently need them, including the territorial defense units, hospitals, clinics, volunteer organizations;
  • Financial support and necessary supplies for Ukrainian migrants – support for Ukrainian migrants on the Romanian and Polish borders to cover living and travel expenses, as well as support for mothers and children in the form of respirators and portable Philips ultrasound devices for use in special medical tents.
  • Program for donations from Philips employees – enabling employees to donate through the Philips Foundation for people in Ukraine.

Roche sent humanitarian aid to the Ministry of Health of Ukraine in the form of medicines and medical devices, namely:

  • Reagents and consumables for HIV, HCV, HBV, and syphilis automated testing. This is necessary to make 120,000 blood donations and ensure the necessary supply of safe blood and blood components;
  • 31,000 units for the treatment of diabetes, including blood glucose monitoring systems and puncture devices;
  • 4,600 packs of drugs for the treatment of lung, breast, and skin cancer, rheumatoid arthritis, spinal muscular atrophy and influenza.

Besides, Roche is committed to providing 150,000 packs of antibiotics for various types of bacterial infections. 75,000 packages of this antibiotic were delivered to the Ministry of Health of Ukraine.

Roche created a special program, Ukrainian Refugee Continuity of Care (UREFCON) to provide ongoing care to displaced Ukrainian patients.

Roche set up a global hotline for patients receiving treatment in Ukraine, participating in clinical trials or Compassionate Drug Use Programme (worldwide: tel: +36 146 182 58, WhatsApp and SMS +36 707 177 394 and e-mail: patientcare@roche.com) to sustain the therapy.

A separate global support program was developed for patients with spinal muscular atrophy (SMA). The program provides uninterrupted access to treatment for all patients in Ukraine or from Ukraine who are currently receiving Roche’s SMA treatment. These include patients receiving Roche’s SMA treatment as part of our clinical trials, pre-registration access/compassionate medications, or other commercial methods (ie, self-funded or government-funded programs in Ukraine). The program supports patients who are currently in Ukraine or those who have left the country due to the war.

Since the first days of the war, Sanofi has been cooperating closely with the Ministry of Health of Ukraine and providing vital drugs to the regions of Ukraine. Globally, the company has provided € 5 million in assistance to the Red Cross in Ukraine and neighbouring European countries to the Office of the United Nations High Commissioner for Refugees. Sanofi coordinates and provides essential medicines and vaccines to support Ukrainian patients and refugees. Sanofi has received 10.5 million single doses (insulins, antiepileptics, emergency medications) that will provide treatment to nearly 360 thousand patients.

Takeda joined the global humanitarian effort and provided 300 million Japanese yen (approximately $ 2.6 million) to the International Federation of Red Cross and Red Crescent Societies for immediate humanitarian assistance on the ground to IDPs and victims of russian aggression. Takeda also transferred UAH 400,000 to the Ukrainian Red Cross. The company provides free medicines to hospitals. Takeda employees make personal donations to several local and global NGOs.

Teva provided charitable assistance with essential medicines in the sum of 11 million US dollars. Teva shipped more than 1.3 million packages of medicines, including antibiotics and other drugs included in the WHO list of essential medicines, as well as products for Ukrainian infants and children suffering from poor sanitation. Teva provided more than 350,000 packages of medicines to the Ministry of Health of Ukraine for 756 thousand US dollars as charitable assistance.

In support of the humanitarian effort, UСB provided € 300,000 to the International Rescue Committee and the Belgian Red Cross. UСB delivered 5,000 antiepileptic drugs and 5,000 antiallergic drugs through Tulipe to help Ukrainian patients.

Wörwag Pharma provided humanitarian aid in the sum of UAH 650,000 for the purchase of essential medicines and donated medicines directly through a Ukrainian charity for 60,000 euros.

The EBA Health Care Committee is very grateful to its member companies for their incredible efforts in ensuring the continued supply of medicines and medical equipment to Ukrainian patients in these difficult times. We are proud of the implementation of this substantial humanitarian support. Devotion to patients is a top priority for the medical and pharmaceutical community, and this priority must be increased especially given the atrocities happening around.

So, we continue to do everything to bring victory to Ukraine as soon as possible! Glory to Ukraine! Glory to the Heroes!

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks

Spelling error report

The following text will be sent to our editors: